FLAVIN

Safety and Efficacy: FLAVIN offers a safe and effective treatment option for patients with progressive keratoconus and corneal ectasia. FLAVIN Isotonic Riboflavin Ophthalmic Solution in Corneal Collagen Cross-linking procedures helps strengthen and stabilize the cornea, thereby halting or slowing disease progression.
Stability: FLAVIN treatment contributes to the stability of vision postoperatively. Patients maintain their corrected distance visual acuity at 12 months following treatment, indicating long-term stability in vision.
Positive Refractive Outcomes: FLAVIN treatment is associated with positive refractive outcomes. Many patients achieve desirable refractive outcomes, such as reduced refractive error and improved visual clarity.
Minimal Corneal Haze: FLAVIN treatment minimizes the occurrence of corneal haze post-treatment. Corneal haze can occur as a side effect of certain ocular procedures and can negatively impact visual clarity. By minimizing corneal haze, FLAVIN helps to ensure clear corneas and improved visual quality for patients.
Preservation of Endothelial Cell Density: FLAVIN treatment preserves endothelial cell density, which is essential for maintaining corneal health. The endothelial cells are responsible for regulating the fluid balance within the cornea, and preserving their density helps to ensure the long-term health and function of the cornea.
Reduced Risk of Complications: FLAVIN treatment is associated with a reduced risk of postoperative complications. Patients experience fewer immediate and long-term complications, leading to a smoother recovery process.
Minimally Invasive Procedure: FLAVIN-assisted treatment is minimally invasive compared to traditional surgical interventions for progressive keratoconus and corneal ectasia. This means that patients experience less trauma and discomfort during the procedure, leading to faster recovery times and improved patient satisfaction.